skip to main content
Idioma:
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy

Arteaga, Edmundo ; de Araújo, Aloir Queiroz ; Bernstein, Mauricio ; Ramires, Felix J A ; Ianni, Barbara Maria ; Fernandes, Fabio ; Mady, Charles

Arquivos brasileiros de cardiologia, 2009-03, Vol.92 (3), p.210-220 [Periódico revisado por pares]

Brazil

Texto completo disponível

Citações Citado por
  • Título:
    Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy
  • Autor: Arteaga, Edmundo ; de Araújo, Aloir Queiroz ; Bernstein, Mauricio ; Ramires, Felix J A ; Ianni, Barbara Maria ; Fernandes, Fabio ; Mady, Charles
  • Assuntos: Adolescent ; Adult ; Cardiomyopathy, Hypertrophic - complications ; Cardiomyopathy, Hypertrophic - diagnosis ; Cardiomyopathy, Hypertrophic - mortality ; Collagen - analysis ; Death, Sudden, Cardiac - etiology ; Epidemiologic Methods ; Female ; Fibrosis ; Humans ; Male ; Middle Aged ; Myocardium - pathology ; Prognosis ; Young Adult
  • É parte de: Arquivos brasileiros de cardiologia, 2009-03, Vol.92 (3), p.210-220
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: In hypertrophic cardiomyopathy (HCM), interstitial myocardial fibrosis is an important histological modification that has been associated with sudden death and evolution toward myocardial dilation. To prospectively evaluate the prognostic value of the collagen volume fraction in HCM. An endomyocardial biopsy of the right ventricle was successfully performed in 21 symptomatic patients with HCM. The myocardial collagen volume fraction (CVF) was determined by histology. The CVF was also determined in fragments of nine normal hearts from subjects deceased from non-cardiac causes. The patients were divided into above-median CVF and below-median CVF groups, and their clinical and echocardiographic characteristics and survival curves were compared. Among the patients, the CVF ranged from 1.86% to 29.9%, median 6.19%; in normal hearts, from 0.13% to 1.46%, median 0.61% (p <0.0001 between HCM and control). There were no significant correlations between CVF and baseline echocardiographic measures. Patients with CVF < or =6.19% and CVF> 6.19% were compared and no baseline differences were observed. However, after an average follow-up period of 110 months, four deaths occurred (two sudden, two due to heart failure) in the group with increased CVF, whereas the patients of the group with lower CVF were all alive at the end of the period (p = 0.02). For the first time, myocardial fibrosis was prospectively associated with a worse prognosis in patients with HCM. Efforts should be directed to the quantification of myocardial fibrosis in HCM, on the premise that its association with the prognosis can aid in the stratification of risk for defibrillator implantation, and in the prescription of drugs that potentially promote myocardial repair.
  • Editor: Brazil
  • Idioma: Inglês;Espanhol
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.